Decrease in Number of Menstrual days after Progesterone Therapy for Management of Dysfunctional Uterine Bleeding

Abstract

Objective: To determine the mean decrease in number of menstrual days from baseline afterprogesterone therapy for management of dysfunctional uterine bleeding.
Methods: This Quasi-experimental study was conducted in Department of Obstetrics and Gynaecology, Unit-II, Services Hospital, Lahore for duration of Six months. Total 125 cases were included in the study through Non-probability, purposive sampling from OPD of Services Hospital, Lahore. Informed consent and demographic information was obtained. Number of menstrual days were asked and noted. Patients were advised to take oral dydrogesterone 10mg two times a day (BD) from 5th menstrual day to 26th day cyclically. Patient was followed in OPD for up to 2nd cycle of every female. After 2 cycles from baseline visit, number of menstrual days was noted on proforma (attached).
Results: The mean age of females was 29.98±7.14 years. The baseline mean duration of menstrual days was 8.56±1.32 days. The mean duration of menstrual days after first cycle was 6.03±1.24 days and the mean duration of menstrual days after second cycle was 5.58±1.14 days. The reduction was significant (p-value=0.000). Thus the mean reduction of menstrual days after
second cycle was 3.00±1.10 days.
Conclusions: Thus it was concluded from results of this study that progesterone therapy is effective in controlling dysfunctional uterine bleeding among females of reproductive age group.